Glycemic Variability of Combination Therapies in T2DM

NCT07442006 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: Empagliflozin/Metformin
DRUG: Anagliptin
DRUG: Metformin
DRUG: Empagliflozin/Linagliptin

Sponsor

JW Pharmaceutical